Lapatinib Terminated Phase 1 Trials for Advanced Solid Tumors Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01497626Lapatinib and Bortezomib in Patients With Advanced Malignancies